Company intelligence / Profile preview

Emergen-C

Foothill Ranch, California, United States
Ownership
Private
Development stage
Other
01

Overview

Emergen-C is a leading consumer healthcare brand that specializes in the development and manufacture of effervescent dietary supplements, primarily focused on vitamin C delivery. Originally founded by Alacer Corp in 1972, the brand is widely recognized for its powdered drink mixes intended to support immune health, enhance energy, and provide electrolyte replacement. The product portfolio has expanded significantly over the decades to include various delivery formats such as gummies, chewables, and crystals, targeting diverse wellness needs including sleep and hydration. In 2012, the brand was acquired by Pfizer, subsequently becoming part of a joint venture with GSK before being spun off into Haleon in 2022. Today, Emergen-C remains a dominant player in the global vitamin and supplement market, distributed extensively through retail and pharmacy channels.

Therapeutic areas
ImmunologyOtherMetabolic Disorders
Modalities
Small moleculeNutraceutical
Industry
Food & Nutrition

Beyond the preview

Go deeper on Emergen-C.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emergen-C.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call